An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2008
This article has no abstract
Epistemonikos ID: 50bbef4c423b31e5aa77bce8c0b83506e8218bdd
First added on: Apr 16, 2025